Allurion Technologies (NYSE:ALUR) today announced the relaunch of its Allurion Balloon in France following regulatory clearance to resume sales. Natick Massachusetts–based Allurion develops the AI-powered gastric balloon for weight loss. The swallowable balloon requires no surgery, endoscopy or anesthesia. Once swallowed, the balloon fills and remains in the stomach for approximately four months before self-emptying […]
Allurion Technologies
Allurion submits weight loss balloon modules to the FDA for premarket approval
Allurion Technologies (NYSE:ALUR) announced today that it submitted three modules for its weight loss balloon to the FDA for premarket approval (PMA). Natick, Massachusetts-based Allurion expects to file the fourth and final module of the PMA early next year. That module contains clinical data from the company’s AUDACITY trial. AUDACITY evaluates the balloon in 550 […]
Allurion could face NYSE delisting
Allurion Technologies (NYSE:ALUR) announced that it received notice from the New York Stock Exchange that it fell out of compliance with listing standards. The NYSE notified Allurion that its stock’s average closing price fell below $1 per share over 30 consecutive trading days ending Aug. 8. This notice does not result in the immediate delisting […]
Allurion pulls weight loss balloon from the French market
Allurion Technologies (NYSE:ALUR) announced today that it suspended sales of its Allurion Balloon from the market in France. The company agreed to suspend sales following a request from the National Medicines Safety Agency (ANSM) in the country. It now proceeds with the withdrawal of its devices from the market, pending the implementation of an action […]
Allurion study says balloon delivers 22% weight loss at one year
Allurion (NYSE:ALUR) today announced data highlighting the success of its balloon technology for weight loss. Natick Massachusetts–based Allurion develops a gastric balloon for weight loss. The swallowable balloon requires no surgery, endoscopy or anesthesia. Once swallowed, the balloon fills and remains in the stomach for approximately four months before self-emptying and passing out naturally. Allurion […]
Allurion appoints new chief operating officer
Allurion (NYSE:ALUR) today announced it appointed Ojas Buch as chief operating officer, effective immediately. Buch will lead the company’s research and development, manufacturing and operations, quality and regulatory, business development, and innovation functions. The company said he will provide strategic and execution-focused guidance to help the company achieve major milestones for its Allurion Gastric Balloon. “We […]
Allurion closes $48 million financing
Allurion (NYSE:ALUR) announced today that it closed a financing of convertible senior secured notes worth $48 million. The company entered into the financing with certain entities managed by RTW Investments. It intends to use proceeds to repay obligations under its existing term loan with Fortress Credit Corp. This reduces the company’s interest expense and increases […]
UK NHS trust treats first patients with Allurion weight loss balloon
Allurion (NYSE:ALUR) announced today that the Somerset NHS Foundation Trust introduced its gastric balloon for weight loss. This marks the first NHS trust in the UK and the first non-private sector organization in the world to introduce the balloon. Natick Massachusetts-based Allurion designed the swallowable balloon to require no surgery, endoscopy or anaesthesia. Once swallowed, […]
Weight loss balloon maker Allurion goes public on NYSE through SPAC merger
Allurion Technologies announced that it completed a SPAC merger and began trading on the New York Stock Exchange. Natick, Massachusetts-based Allurion went public on Aug. 2 under the ALUR ticker. The business combination took place with Compute Health Acquisition Corp, a special purpose acquisition company (SPAC). Allurion develops an artificial intelligence-powered weight loss program. Its program […]
Medtronic, Allurion partner on AI-based weight loss tech
Allurion announced today that it entered into a pilot collaboration with Medtronic . Allurion and Medtronic inked a sales agency agreement in the Central and Eastern Europe, Middle East, and Africa (CEMA) region. The agreement aims to expand access to Allurion’s artificial intelligence-powered weight loss program. It enables Allurion to offer its Allurion Balloon and […]
Allurion Technologies appoints three new executives
Allurion Technologies this week said it appointed three new executives. Whitney Cypes was appointed VP of global marketing. Cypes has more than 15 years of global marketing of medical devices experience. Prior to joining Allurion, Cypes was the senior director of marketing at Insulet. She has also held a number of leadership roles at Hologic, […]
